Name | Taltirelin |
Synonyms | TA 0910 Taltirelin Ceredist, TA-0910 Taltirelin interMediate TALTIRELIN INTERMEDIATES Taltirelin Acetate,TA-0910 L-Prolinamide,(4S)-hexahydro-1-methyl- 2,6-dioxo-4-pyrimidinecarbonyl-L-histidyl- (4S)-Hexahydro-1-Methyl-2,6-dioxo-4-pyriMidinecarbonyl-L-histidyl- N-{[(4S)-1-methyl-2,6-dioxohexahydropyrimidin-4-yl]carbonyl}-L-histidyl-L-prolinamide L-Prolinamide, N-[(hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl]-L-histidyl-, (S)- L-Prolinamide, N-[[(4S)-hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl]carbonyl]-L-histidyl- (9CI) (4S)-N-[(2S)-1-[(2S)-2-Carbamoylpyrrolidin-1-yl]-3-(3H-imidazol-4-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide |
CAS | 103300-74-9 |
InChI | InChI=1/C17H23N7O5/c1-23-13(25)6-10(22-17(23)29)15(27)21-11(5-9-7-19-8-20-9)16(28)24-4-2-3-12(24)14(18)26/h7-8,10-12H,2-6H2,1H3,(H2,18,26)(H,19,20)(H,21,27)(H,22,29)/t10-,11-,12-/m0/s1 |
Molecular Formula | C17H23N7O5 |
Molar Mass | 405.41 |
Density | 1.447±0.06 g/cm3(Predicted) |
Melting Point | 72-75° |
Specific Rotation(α) | 25D -13.6° (c = 1 in water) |
pKa | 9.32±0.40(Predicted) |
Storage Condition | Store at +4°C |
Refractive Index | 1.611 |
oral thyrotropin-releasing hormone | , it was successfully developed by Mitsubishi Pharmaceutical Co., Ltd., Japan, and its trade name is taltielin. It belongs to the 3.1 class of new chemical drugs. At present, it is the most effective drug for improving the movement disorder of patients with spinocerebellar degeneration.|
biological activity | taltielin (TA0910) is a thyrotropin-releasing hormone receptor (TRH-R) superagonist, the IC50 value was 910 nM and the EC50 value for stimulating an increase in cytosolic Ca2 concentration (Ca2 release) was 36 nM. |
Target | IC50: 910 nM |